Lanlan Zhou

Years Active: 2017-2018
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Varun V Prabhu, Mala K Talekar, Amriti R Lulla, C Leah B Kline, Lanlan Zhou, Junior Hall, A Pieter J Van den Heuvel, David T Dicker, Jawad Babar, Stephan A Grupp, Mathew J Garnett, Ultan McDermott, Cyril H Benes, Jeffrey J Pu, David F Claxton, Nadia Khan, Wolfgang Oster, Joshua E Allen, Wafik S El-Deiry
Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies. Cell cycle (Georgetown, Tex.) 17 (4) (2018)
Jun Zhang, Lanlan Zhou, Shuai Zhao, David T Dicker, Wafik S El-Deiry
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia. Cell cycle (Georgetown, Tex.) 16 (12) (2017)
Jessica Wagner, Christina Leah Kline, Marie D Ralff, Avital Lev, Amriti R Lulla, Lanlan Zhou, Gary L Olson, Bhaskara Rao Nallaganchu, Cyril H Benes, Joshua E Allen, Varun V Prabhu, Martin Stogniew, Wolfgang Oster, Wafik S El-Deiry
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212. Cell cycle (Georgetown, Tex.) 16 (19) (2017)
Joshua E Meyer, Niklas K Finnberg, Lili Chen, Dusica Cvetkovic, Bin Wang, Lanlan Zhou, Yanqun Dong, Mark A Hallman, Chang-Ming C Ma, Wafik S El-Deiry
Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation. Cell cycle (Georgetown, Tex.) 16 (12) (2017)

Lanlan Zhou.css-eqlu8i{font-size:small;padding-left:4px;}